Immunovia AB (publ) (STO:IMMNOV)
Sweden · Delayed Price · Currency is SEK 0.1624
-0.0046 (-2.75%)
At close: Mar 27, 2026
Immunovia AB Market Cap
Immunovia AB has a market cap or net worth of 109.24 million as of March 27, 2026. Its market cap has increased by 27.16% in one year.
Market Cap
109.24M
Enterprise Value
32.64M
Revenue
685.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.16
Market Cap Chart
Since December 1, 2015, Immunovia AB's market cap has decreased from 424.45M to 109.24M, a decrease of -74.26%. That is a compound annual growth rate of -12.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 109.24M | -28.46% |
| Dec 30, 2025 | 152.70M | 64.79% |
| Dec 30, 2024 | 92.66M | 15.47% |
| Dec 29, 2023 | 80.25M | -86.52% |
| Dec 30, 2022 | 595.21M | -64.93% |
| Dec 30, 2021 | 1.70B | -37.08% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 133.29B |
| Getinge AB | 50.25B |
| Sectra AB | 42.12B |
| Medicover AB | 27.96B |
| Arcoma AB | 117.62M |
| Scandinavian Real Heart AB (Publ) | 114.72M |
| Active Biotech AB | 114.67M |
| Iconovo AB | 113.96M |